InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
5
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+76.1%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by McClurg Ronald W., Chief Financial Officer. Insider active across 1 company, notably NEUROONE MEDICAL TECHNOLOGIES Corp. In total, 8 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €175k. Activity tracked since 3 February 2022. The latest transaction was disclosed on 4 April 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to McClurg Ronald W.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
200,000 shares@ US$0.5051.8% of flowCommon StockSEC:0001837830-25-000001:0
Canonical exit: 3 Jul 2025 (T+90)
113,717 shares0Common StockSEC:0001837830-24-000001:0
50,900 shares@ US$0.982826.6% of flowCommon StockSEC:0001837830-23-000002:0
Canonical exit: 12 Dec 2023 (T+90)
12,500 shares0Common StockSEC:0001837830-23-000001:0
10,000 shares@ US$1.02190.022% mcap25.9% of flowCommon StockSEC:0001837830-22-000004:0
Canonical exit: 13 Sept 2022 (T+90)
14,000 shares@ US$1.05580.031% mcap36.8% of flowCommon StockSEC:0001837830-22-000003:0
Canonical exit: 8 Sept 2022 (T+90)
17,500 shares@ US$0.85280.032% mcap37.3% of flowCommon StockSEC:0001837830-22-000002:0
Canonical exit: 18 Aug 2022 (T+90)
15,000 shares0Common StockSEC:0001837830-22-000001:0
8 of 8 declarations
About McClurg Ronald W.
Ronald W. McClurg is the Chief Financial Officer of NeuroOne Medical Technologies Corp. He is responsible for the company's financial management, including budgeting and risk management. With a strong background in finance, he plays a key role in the financial strategy and performance of the company.
